US AAA–AA Healthcare & Pharmaceuticals Corporate Bond Yields (USD)
Fitted spot curve as of 2026-10-26
https://bondscovery.com/yield-curve/usd-corporate-aaa-aa-healthcare-pharmaceuticals
US AAA–AA Healthcare & Pharmaceuticals Corporate Bond Yields (USD) as of 2026-10-26: 10Y at 5.45%, fitted curve 1M–40Y (4.39%–6.08%), 137 bonds. Live chart, constituents and forward rates on bondScovery.
| Maturity | Fitted yield | Forward rate |
|---|---|---|
| 1M | 4.39% | — |
| 3M | 4.42% | 4.44% |
| 6M | 4.48% | 4.63% |
| 9M | 4.54% | 4.82% |
| 12M | 4.62% | 4.82% |
| 18M | 4.75% | 5.07% |
| 2Y | 4.83% | 5.18% |
| 3Y | 4.97% | 5.34% |
| 4Y | 5.09% | 5.56% |
| 5Y | 5.19% | 5.73% |
| 6Y | 5.27% | 5.83% |
| 7Y | 5.33% | 5.87% |
| 8Y | 5.38% | 5.88% |
| 9Y | 5.42% | 5.89% |
| 10Y | 5.45% | 5.93% |
| 15Y | 5.70% | 6.64% |
| 20Y | 5.92% | 7.30% |
| 25Y | 5.99% | 6.70% |
| 30Y | 6.01% | 6.55% |
| 40Y | 6.08% | 6.99% |
2Y, 10Y and the 10Y−2Y spread over time
The 2-year yield is 4.83% and the 10-year 5.45%, a 10Y−2Y spread of +62 bp — positively sloped — as of 2026-10-26. The chart and table below track how they have moved.
Fitted 2Y and 10Y yields and their spread, sampled one build date per month. See all inverted curves today →
| Tenor | Latest2026-10-26 | 1m ago2026-09-25 | 2m ago2026-08-27 | 3m ago2026-07-28 | 4m ago2026-06-29 | 5m ago2026-05-29 | 6m ago2026-04-29 |
|---|---|---|---|---|---|---|---|
| 2Y | 4.83% | 4.99% | 4.46% | 4.52% | 4.31% | 4.30% | 4.12% |
| 10Y | 5.45% | 5.59% | 5.24% | 5.24% | 4.95% | 5.04% | 4.92% |
| 10Y − 2Y | +62 bp | +60 bp | +78 bp | +72 bp | +64 bp | +75 bp | +79 bp |
Bonds in this curve
A selection of 30 of the 138 bonds behind this curve, spread across maturities.
| Issuer | Yield | Maturity | Coupon | ISIN |
|---|---|---|---|---|
| Roche Holding | 4.55% | 2026-11-13 | 5.26% | US771196CE02 |
| ELI Lilly | 4.39% | 2027-02-09 | 4.50% | US532457CJ56 |
| Novartis | 4.08% | 2027-02-14 | 2.00% | US66989HAQ11 |
| Roche Holding | 4.49% | 2027-03-10 | 2.31% | US771196BV36 |
| ELI Lilly | 4.59% | 2027-03-15 | 5.50% | US532457AZ17 |
| ELI Lilly | 4.49% | 2027-08-14 | 4.15% | US532457CP17 |
| Johnson & Johnson | 4.35% | 2027-09-01 | 0.95% | US478160CP78 |
| Sanofi SA | 4.64% | 2027-11-03 | 3.75% | US801060AE44 |
| Johnson & Johnson | 4.63% | 2028-01-15 | 2.90% | US478160CK81 |
| ELI Lilly | 4.62% | 2028-02-12 | 4.55% | US532457CU02 |
| Johnson & Johnson | 4.63% | 2028-03-01 | 4.55% | US478160DH44 |
| Roche Holding | 4.90% | 2028-09-17 | 3.62% | USU75000BP05 |
| ELI Lilly | 4.75% | 2028-10-15 | 4.00% | US532457DB12 |
| Johnson & Johnson | 4.74% | 2029-06-01 | 4.80% | US478160CU63 |
| ELI Lilly | 4.84% | 2029-05-20 | 4.15% | US532457DK11 |
| Novartis | 5.07% | 2030-08-14 | 2.20% | US66989HAR93 |
| Roche Holding | 5.23% | 2030-11-13 | 5.49% | USU75000CG96 |
| ELI Lilly | 5.13% | 2031-05-20 | 4.38% | US532457DL93 |
| Johnson & Johnson | 4.92% | 2031-06-01 | 4.90% | US478160CV47 |
| ELI Lilly | 5.19% | 2032-10-15 | 4.55% | US532457DD77 |
| Sanofi SA | 5.17% | 2032-11-03 | 4.20% | US801060AJ31 |
| Roche Holding | 5.43% | 2033-11-13 | 5.59% | USU75000CH79 |
| Roche Holding | 5.39% | 2034-09-09 | 4.59% | USU75000CQ78 |
| ELI Lilly | 5.45% | 2035-10-15 | 4.90% | US532457DE50 |
| ELI Lilly | 5.60% | 2036-05-20 | 4.85% | US532457DR63 |
| Johnson & Johnson | 5.53% | 2040-09-01 | 4.50% | US478160AV64 |
| Roche Holding | 5.89% | 2044-11-28 | 4.00% | USU75000BG06 |
| Roche Holding | 5.92% | 2051-12-13 | 2.61% | USU75000BY12 |
| Johnson & Johnson | 5.70% | 2054-06-01 | 5.25% | US478160CX03 |
| ELI Lilly | 6.11% | 2063-02-27 | 4.95% | US532457CH90 |